Skip to content

Net Change in Cash at other companies

Boston Scientific logo
Boston ScientificBSX
-$504M-261%
AngioDynamics logo
AngioDynamicsANGO
-$3.83M+59.0%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
-$1.08M-210%
Delcath Systems logo
Delcath SystemsDCTH
-$2.14M+89.1%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$8.45M+21.4%
LQD
Liquidia CorporationLQDA
$32.11M+578%

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s net change in cash?
TriSalus Life Sciences, Inc. (TLSI) reported net change in cash of $35.76M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s net change in cash changed year-over-year?
TriSalus Life Sciences, Inc.'s net change in cash increased by 699.2% year-over-year, from $4.48M to $35.76M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s net change in cash?
Over 2 years (2021 to 2024), TriSalus Life Sciences, Inc.'s net change in cash has grown at a 69.3% compound annual growth rate (CAGR), from -$1.13M to -$3.25M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.